Member Info for soulac

I think if they go above the 29% they have to make an offer for the company, not a 100% sure ,

Maybe someone else knows,

Braveheart investment

Not many free float Bray investment hold 29%

Not for long it’s on the radar now, hopefully see some more delayed buys

Think this could have a good run now, been picked up by a lot of pi,

Red have you started selling again, lol

IQAI

On the move

I only pop in here for a quick trade,

But I done a lot of reading and there’s so much going for this company, you guys must be frustrated with the sp,

I will leave my investment here and see how this plays out, only needs one deal , imo

Gla

10k delayed buy ,

Been read this this morning there’s a lot going on and a lot of news due, it could do very well,

IMHO

And iqai have done a deal with them. Big things to happen over there.

He has a lot of confidence in AI

I personally believe the day will eventually come when AI helps us change the “C” word from “cancer” to “cure.” The technology is improving how radiologists detect and treat cancer by enhancing image analysis, reducing errors, predicting treatment outcomes, and enabling personalized care. While AI will never be a substitute for human medical expertise, I predict that 2025 will showcase many more examples of AI’s ability to improve the lives of cancer patients and the care offered by their providers.

Https://www.auntminnie.com/imaging-informatics/artificial-intelligence/article/15712005/ge-healthcare-ai-will-transform-early-cancer-detection-save-lives-in-2025

RNS 15th October,

Lots of news flow to come,

("IQ-AI" or the "Company")

New Patent Application, Trading Update and

Commencement of discussions with potential phase 2 partners

IQ-AI (LSE: IQAI) Imaging Biometrics ("IB") has filed a provisional patent application with the United States Patent and Trademark Office ("USPTO") "Gallium Maltolate (GaM) as a Cancer Treatment Agent and Method". Provisional patents are routinely used to secure an early filing date while an invention is being developed and refined.

The Company is also pleased to report that the growth in IQ-AI's revenues, first reported at the time of our Interim Report in August, has continued. The Board now expects that total revenue for the current year will thus be between U$900,000 and U$1million. This expected material year-on-year sales increase (up from U$760,000 in 2023), has primarily been driven by sales of our software solutions.

As we have previously advised, the phase 1 clinical trial is nearing its conclusion. We have now commenced discussions with potential partners to provide funding for a phase 2 trial.

"We are extremely pleased with the revenue performance this year," said Trevor Brown, CEO of IQ-AI. "and we remain hopeful that revenue will continue to build as software innovations come on stream. Regarding IB003, the planning for a phase 2 trial will move to the centre of our attention which includes discussions with potential funding partners."

IQAI

Starting a move, Braveheart investments took 29% of the share a few weeks ago,

Will start to move up now ,

Always good to top slice, thanks

Lol

Good time to accumulate why there’s a seller around, got a few more,

And another 5k